Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

High-dose procainamide in chronic renal failure.

M B Bottorff, C S Kuo, R L Batenhorst

    Drug Intelligence & Clinical Pharmacy
    |April 1, 1983
    PubMed
    Summary

    Procainamide (PA) successfully treated ventricular tachycardia in chronic renal failure. Maintaining serum PA levels above 8 µg/ml prevented recurrent arrhythmias, optimizing patient response.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Composite prism-grating coupler for coupling light into high refractive index thin-film waveguides.

    Applied optics·2010
    Same author

    Comparative cytotoxicity of five root canal sealers on cultured human periodontal ligament fibroblasts.

    International endodontic journal·2010
    Same author

    Surrogate estimates of insulin sensitivity in Chinese diabetic patients and their offspring.

    Diabetic medicine : a journal of the British Diabetic Association·2002
    Same author

    Exacerbation of insulin resistance and postprandial triglyceride response in newly diagnosed hypertensive patients with hypertriglyceridaemia.

    Journal of human hypertension·2002
    Same author

    Waist circumference predicts insulin resistance in offspring of diabetic patients.

    Diabetes, nutrition & metabolism·2002
    Same author

    Propylthiouracil-induced hemolytic anemia.

    Zhonghua yi xue za zhi = Chinese medical journal; Free China ed·2002

    Area of Science:

    • Pharmacology
    • Nephrology
    • Cardiology

    Background:

    • Chronic renal failure (CRF) poses challenges in managing cardiac arrhythmias.
    • Ventricular tachycardia (VT) is a serious arrhythmia requiring effective treatment.

    Observation:

    • A patient with CRF presented with symptomatic VT.
    • Successful treatment with procainamide (PA) was achieved after careful dosage titration.

    Findings:

    • Optimal therapeutic response and prevention of VT recurrence were linked to specific serum concentrations of procainamide (PA) and its active metabolite N-acetylprocainamide (NAPA).
    • Sustained ventricular ectopy occurred when serum PA levels dropped below 8 µg/ml.
    • Targeting combined serum levels of PA and NAPA between 20-30 µg/ml was crucial for sustained efficacy.

    Implications:

    • This case highlights the importance of therapeutic drug monitoring for procainamide in patients with renal impairment.
    • Individualized dosage adjustments are essential to balance efficacy and toxicity in managing VT in CRF.
    • Understanding the pharmacokinetic-pharmacodynamic relationship of PA and NAPA is critical for effective arrhythmia management in renally impaired patients.

    Related Experiment Videos